Submitted by Anonymous (not verified) on 20 November 2023 - 11:38
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Lymphoma, Mantle-Cell, Date of authorisation: 30/10/2023, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Lymphoma, Mantle-Cell, Date of authorisation: 30/10/2023, Status: Authorised